In September 2020, Occuity successfully raised over £1.1M in Investment funding. This funding has enabled us to continue the development of our novel optical products to screen, diagnose and monitor chronic health conditions such as diabetes and Alzheimer’s Disease. Please read our press release here.
Occuity have a clear mission to improve the screening and monitoring of some of humanities greatest health challenges including diabetes and Alzheimer's Disease, both of which are growing challenges. With our novel optical technologies protected by nine granted international patents (plus four more in application), we are excited about continuing the research and development of our products and launching our first product – a handheld non-contacting optical pachymeter – in Q2 2021.
Request our October 2020 Investor Update
If you are interested in future investment opportunities or would like further information, please contact us using the form below to request our most recent 'Investor Update' and be added to our mailing list.”